首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   109298篇
  免费   11362篇
  国内免费   6928篇
耳鼻咽喉   1056篇
儿科学   1623篇
妇产科学   792篇
基础医学   8941篇
口腔科学   1637篇
临床医学   13617篇
内科学   12335篇
皮肤病学   1152篇
神经病学   3854篇
特种医学   4121篇
外国民族医学   30篇
外科学   9619篇
综合类   25914篇
现状与发展   20篇
一般理论   12篇
预防医学   11389篇
眼科学   2218篇
药学   12684篇
  170篇
中国医学   9707篇
肿瘤学   6697篇
  2024年   522篇
  2023年   1633篇
  2022年   3877篇
  2021年   5063篇
  2020年   4174篇
  2019年   3030篇
  2018年   2956篇
  2017年   3475篇
  2016年   3061篇
  2015年   4789篇
  2014年   6297篇
  2013年   6950篇
  2012年   9506篇
  2011年   10260篇
  2010年   8487篇
  2009年   7147篇
  2008年   7597篇
  2007年   7329篇
  2006年   6628篇
  2005年   5499篇
  2004年   4080篇
  2003年   3825篇
  2002年   3197篇
  2001年   2538篇
  2000年   1767篇
  1999年   996篇
  1998年   453篇
  1997年   536篇
  1996年   383篇
  1995年   277篇
  1994年   236篇
  1993年   163篇
  1992年   138篇
  1991年   132篇
  1990年   102篇
  1989年   111篇
  1988年   57篇
  1987年   67篇
  1986年   50篇
  1985年   49篇
  1984年   20篇
  1983年   26篇
  1982年   16篇
  1981年   13篇
  1980年   7篇
  1979年   20篇
  1978年   10篇
  1977年   10篇
  1976年   5篇
  1975年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
The Microbact 24E (MB24E) system is a commercial microsystem for the identification of common clinical isolates of Enterobacteriaceae and non-fermenting Gram negative bacilli, and consists of dehydrated substrates distributed in the wells of microtitre trays. This system was compared with the API20E for the identification of 386 bacterial isolates, which included 284 clinical and 102 environmental organisms. There was 97% and 91% agreement for the identification of clinical isolates of Enterobacteriaceae and other Gram negative bacilli, respectively. The identification of environmental isolates by both systems was less satisfactory. The API20E has a more extensive database than the MB24E and is thus more reliable for the identification of rare or unusual organisms, but the MB24E is cheaper, is easy and convenient to use, and is suitable for a routine microbiology laboratory.  相似文献   
62.
63.
Application of Serum-Free Culture Medium for Preparation of A-NK Cells   总被引:4,自引:0,他引:4  
To compare the differences between proliferation and cytotoxicity of adherent natural killer (A-NK) cells cultured with serum-free medium AIMV and standard serum-containing medium in vitro, and also observe the assisting effect of IL-12 on the activation and the morphology character of IL-2-treated A-NK cells, cellular proliferation was evaluated by MTT method in vitro. The morphology of the target cells killed by A-NK cells was observed through electroscope. All of the A-NK cells cultured in serum-free medium AIMV could rapidly proliferate and keep high cytotoxicity compared with that in standard serum-containing medium. A-NK cells activated by both moderate-dose IL-2 and IL-12 were superior to the high-dose IL-2-treated A-NK cells. These data indicated that serum-free medium AIMV could replace standard serum-containing medium for culturing A-NK cells, and moderate-dose IL-2 and IL-12 could reduce side effects caused by high-dose IL-2. The study provided a new experimental basis for experimental and clinical preparation of A-NK cells. Cellular & Molecular Immunology.  相似文献   
64.
In the present study we prepared macroporous polyvinyl alcohol beads. A series of bilirubin adsorbents were generated by immobilization of eight amine agents to the beads as ligands. The adsorption of bilirubin was evaluated by in vitro static and dynamic adsorption tests. The results show that these adsorbents have excellent adsorption efficiency and capacity. Among the eight ligands, trimethylamine (TMA), triethylamine (TEA) and 1,6- hexanediamine(HDA) showed the highest adsorption capacity. The adsorption equilibrium can be achieved in half an hour, and the adsorption percentage of bilirubin was up to 80%. Static electricity and hydrophobic interaction played the main role in bilirubin adsorption, and the adsorption was found to match the monolayer model. The excellent adsorption of these adsorbents indicates their potential in clinical treatment.  相似文献   
65.
BACKGROUND: Severe acute respiratory syndrome (SARS) became a worldwide outbreak with a mortality of 9.2%. This new human emergent infectious disease is dominated by severe lower respiratory illness and is aetiologically linked to a new coronavirus (SARS-CoV). METHODS: Pulmonary pathology and clinical correlates were investigated in seven patients who died of SARS in whom there was a strong epidemiological link. Investigations include a review of clinical features, morphological assessment, histochemical and immunohistochemical stainings, ultrastructural study, and virological investigations in postmortem tissue. RESULTS: Positive viral culture for coronavirus was detected in most premortem nasopharyngeal aspirate specimens (five of six) and postmortem lung tissues (two of seven). Viral particles, consistent with coronavirus, could be detected in lung pneumocytes in most of the patients. These features suggested that pneumocytes are probably the primary target of infection. The pathological features were dominated by diffuse alveolar damage, with the presence of multinucleated pneumocytes. Fibrogranulation tissue proliferation in small airways and airspaces (bronchiolitis obliterans organising pneumonia-like lesions) in subpleural locations was also seen in some patients. CONCLUSIONS: Viable SARS-CoV could be isolated from postmortem tissues. Postmortem examination allows tissue to be sampled for virological investigations and ultrastructural examination, and when coupled with the appropriate lung morphological changes, is valuable to confirm the diagnosis of SARS-CoV, particularly in clinically unapparent or suspicious but unconfirmed cases.  相似文献   
66.
目的:探讨肩胛骨前后联合入路治疗陈旧性浮肩损伤的临床疗效。方法:采用肩胛骨前后联合入路对6例陈旧性浮肩损伤进行手术治疗。结果:根据Herscovici功能评估标准,其中优1例,良2例,可3例,无血管神经副损伤。结论:采用肩胛骨前后联合入路处理陈旧性浮肩损伤,术野显露清楚,易于操作与复位固定,可以有效地避开血管神经,安全可靠。  相似文献   
67.
Glutaric acidemia type I is caused by mutations of the glutaryl-CoA dehydrogenase (GCDH) gene resulting in loss of GCDH enzyme activity. Patients present with progressive dystonia and lesions in basal ganglia. Dietary treatment, when instituted from the early neonatal period, markedly reduces dystonia and morbidity. Early diagnosis and prenatal diagnosis will be facilitated by knowledge of locally prevalent GCDH mutations. Several common GCDH mutations have been found in different ethnic groups. GCDH mutations were studied in 5 Chinese glutaric acidemia type I families. We detected two novel recurrent mutations (A219T and IVS10-2A>C) which were found in two unrelated families. An asymptomatic carrier of IVS10-2A>C was also found on screening of 120 individuals. Other mutations were identified, including two other novel (R386G & IVS3+1G>A) and two known mutations (G178R & R355H). Fibroblasts from patients carrying the novel mutations were confirmed to be deficient for GCDH activity. This is the first report of GCDH mutations describing recurrent mutations in Chinese patients. The carrier rate of IVS10-2A>C may be particularly high in Chinese.  相似文献   
68.
重复电刺激前肢神经引起成年大鼠运动皮层的可塑性改变   总被引:2,自引:0,他引:2  
为了了解成年大鼠运动皮层的功能可塑性,利用皮层内微刺激方法测定MI代表区并观察重复电刺激前肢神经对MI代表区的影响。实验组大鼠(9例)持续1.2-2小时的前肢神经电刺激导致前肢运动区与面部触须运动区边界向VI方向,移动263.3±90.9μm并同时伴有运动阈值的改变;FL内MT降低5.0±13.3μA,而在VI内MT升高9.6±11.6μA对照组大鼠间隔1.5-2小时的两次测定结果,FL-VI边界  相似文献   
69.
HLA-DR、DQ等位基因与精神分裂症相关性的研究   总被引:2,自引:0,他引:2  
周杰  刘辉 《免疫学杂志》2004,20(5):385-389
目的 证明HLA-DR、DQ等位基因与精神分裂症的发病密切相关。方法 HLA-DR、DQ等位基因检测:PCR-SSP分型。结果 发现在大连地区随机选择的精神分裂症患者的HLA-DQ8基因的频率(9.0%)明显高于正常对照(2.5%)。精神分裂症患者的HLA-DR、DQ等位基因的某些位点与免疫指标的改变有相关性。结论 ①HLA-DQ8基因与精神分裂症有关联,可以认为HLA-DQ8基因可能是精神分裂症的易感基因。②HLA-DR、DQ等位基因的某些组合可能是精神分裂症发病的危险组合模式,对预测精神分裂症的基因易感性具有潜在的应用价值。③精神分裂症的免疫指标的改变与HLA-DR、DQ等位基因的某些位点有相关性,说明精神分裂症与它的免疫指标的变化可能有内在的联系。  相似文献   
70.
目的 进一步研究NOD小鼠T细胞应答改变机理。方法 用抗TCR抗体、ConA激活NOD小鼠胸腺细胞,分析TCR介导的信号通路的水平。结果 与Balb/c小鼠胸腺细胞相比,抗TCR抗体诱导的增殖应答较弱,与年龄及NOD胸腺CD4^ CD8^-和CD4^-CD8^ SP细胞有关;rIL-2能部分恢复对TCR抗体应答的缺乏。NOD小鼠对PMA IONO和PMA anti—TCR-mAb应答正常,但对anti-TCRmAb IONO应答缺乏。结论 与年龄有关的NOD小鼠胸腺细胞对TCR抗体应答的缺乏与T细胞激活时上游PKC信号通路的缺乏有关。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号